2014 Executive Compensation Schedule for NewLink Genetics Corporation

Summary

This document outlines the 2014 compensation details for key executives of NewLink Genetics Corporation, including Charles J. Link, Jr., Nicholas N. Vahanian, Gordon H. Link, Jr., and W. Jay Ramsey. It specifies each executive's base salary, target bonus as a percentage of 2013 salary, total cash bonus target, and the number of stock options and restricted stock unit awards to be granted. The agreement sets forth the company's compensation structure for its top officers for the year 2014.

EX-10.2 3 nlnk-20140108x8kxex102.htm 2014 SALARIES, BONUS TARGETS AND EQUITY AWARDS NLNK-20140108-8K-EX10.2
Exhibit 10.2


2014 Salaries, Bonus Targets and Equity Awards
 
 
 
 
 
 
Name and Title
2014 Salary
Bonus Target*
Total Cash Bonus Target
Stock Options
Restricted Stock Unit Awards
Charles J. Link, Jr., M.D.
$573,200
60%
$343,920
108,750
23,000
Chairman of the Board and Chief Executive and Scientific Officer
 
 

 

Nicholas N. Vahanian, M.D.
$453,600
50%
$226,800
71,250
15,000
President and Chief Medical Officer
 
 

 

Gordon H. Link, Jr.
$295,200
35%
$103,320
27,000
5,700
Chief Financial Officer
 
 

 

W. Jay Ramsey, M.D., Ph.D.
$312,200
35%
$109,270
32,250
6,800
Quality Assurance Officer
 
 
 
 
 
*Bonus Targets listed as percentage of 2013 Base Salary